Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/a-1998-4578 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
F-FLT PET in Gastrointestinal Graft versus Host Disease: An Emerging Paradigm.
Radiol Imaging Cancer
March 2025
Department of Radiology, University of Pennsylvania, 3400 Spruce St, 1 Silverstein, Philadelphia, PA 19104-6243.
Commentary: Long-Term Outcomes After CyberKnife Radiosurgery for Nonfunctioning Pituitary Adenomas.
Neurosurgery
April 2025
Department of Neurosurgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Commentary: Is It Justified to Sacrifice the Pituitary Stalk During Craniopharyngioma Surgery? A Systematic Review and Meta-Analysis.
Neurosurgery
April 2025
Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Commentary: Endoscopic Extended Transsphenoidal Surgery for Transbasal Tuberculum Sellae Meningioma: 2-Dimensional Operative Video.
Oper Neurosurg (Hagerstown)
April 2025
Department of Neurological Surgery, University of Washington School of Medicine, Seattle, Washington, USA.
Fighting resistance with redundancy: a path forward for treating antimicrobial-resistant infections?
Antimicrob Agents Chemother
March 2025
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Carbapenem-resistant (CRAB) remains a major threat, with high mortality and limited effective treatments. Sulbactam-durlobactam has emerged as a promising therapy against CRAB. Sulbactam-durlobactam was combined with imipenem-cilastatin in a clinical trial that led to its United States Food and Drug Administration approval.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!